0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis C Virus (HCV) Market Insights, Forecast to 2028
Published Date: November 2022
|
Report Code: QYRE-Auto-36F5982
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hepatitis C Virus HCV Market Insights Forecast to 2028
BUY CHAPTERS

Global Hepatitis C Virus (HCV) Market Insights, Forecast to 2028

Code: QYRE-Auto-36F5982
Report
November 2022
Pages:126
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Hepatitis C Virus (HCV) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Hepatitis C Virus (HCV) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Hepatitis C Virus (HCV) market. Further, it explains the major drivers and regional dynamics of the global Hepatitis C Virus (HCV) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Hepatitis C Virus (HCV) Segment by Type

Hepatitis C Drugs
Hepatitis C Test Kit

Hepatitis C Virus (HCV) Segment by Application

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hepatitis C Virus (HCV) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Hepatitis C Virus (HCV) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Hepatitis C Virus (HCV), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hepatitis C Virus (HCV), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hepatitis C Virus (HCV) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Hepatitis C Virus (HCV) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Hepatitis C Virus (HCV) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Gilead, Merck, AbbVie, J&J, Bristol-Myers Squibb, Kawin, Abbott, Siemens Healthineers and Roche Diagnostics, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hepatitis C Virus (HCV) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis C Virus (HCV) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hepatitis C Drugs
1.2.3 Hepatitis C Test Kit
1.3 Market by Application
1.3.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Virus (HCV) Market Perspective (2017-2028)
2.2 Hepatitis C Virus (HCV) Growth Trends by Region
2.2.1 Hepatitis C Virus (HCV) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hepatitis C Virus (HCV) Historic Market Size by Region (2017-2022)
2.2.3 Hepatitis C Virus (HCV) Forecasted Market Size by Region (2023-2028)
2.3 Hepatitis C Virus (HCV) Market Dynamics
2.3.1 Hepatitis C Virus (HCV) Industry Trends
2.3.2 Hepatitis C Virus (HCV) Market Drivers
2.3.3 Hepatitis C Virus (HCV) Market Challenges
2.3.4 Hepatitis C Virus (HCV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus (HCV) Players by Revenue
3.1.1 Global Top Hepatitis C Virus (HCV) Players by Revenue (2017-2022)
3.1.2 Global Hepatitis C Virus (HCV) Revenue Market Share by Players (2017-2022)
3.2 Global Hepatitis C Virus (HCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Revenue
3.4 Global Hepatitis C Virus (HCV) Market Concentration Ratio
3.4.1 Global Hepatitis C Virus (HCV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Revenue in 2021
3.5 Hepatitis C Virus (HCV) Key Players Head office and Area Served
3.6 Key Players Hepatitis C Virus (HCV) Product Solution and Service
3.7 Date of Enter into Hepatitis C Virus (HCV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Virus (HCV) Breakdown Data by Type
4.1 Global Hepatitis C Virus (HCV) Historic Market Size by Type (2017-2022)
4.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2023-2028)
5 Hepatitis C Virus (HCV) Breakdown Data by Application
5.1 Global Hepatitis C Virus (HCV) Historic Market Size by Application (2017-2022)
5.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hepatitis C Virus (HCV) Market Size (2017-2028)
6.2 North America Hepatitis C Virus (HCV) Market Size by Type
6.2.1 North America Hepatitis C Virus (HCV) Market Size by Type (2017-2022)
6.2.2 North America Hepatitis C Virus (HCV) Market Size by Type (2023-2028)
6.2.3 North America Hepatitis C Virus (HCV) Market Share by Type (2017-2028)
6.3 North America Hepatitis C Virus (HCV) Market Size by Application
6.3.1 North America Hepatitis C Virus (HCV) Market Size by Application (2017-2022)
6.3.2 North America Hepatitis C Virus (HCV) Market Size by Application (2023-2028)
6.3.3 North America Hepatitis C Virus (HCV) Market Share by Application (2017-2028)
6.4 North America Hepatitis C Virus (HCV) Market Size by Country
6.4.1 North America Hepatitis C Virus (HCV) Market Size by Country (2017-2022)
6.4.2 North America Hepatitis C Virus (HCV) Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hepatitis C Virus (HCV) Market Size (2017-2028)
7.2 Europe Hepatitis C Virus (HCV) Market Size by Type
7.2.1 Europe Hepatitis C Virus (HCV) Market Size by Type (2017-2022)
7.2.2 Europe Hepatitis C Virus (HCV) Market Size by Type (2023-2028)
7.2.3 Europe Hepatitis C Virus (HCV) Market Share by Type (2017-2028)
7.3 Europe Hepatitis C Virus (HCV) Market Size by Application
7.3.1 Europe Hepatitis C Virus (HCV) Market Size by Application (2017-2022)
7.3.2 Europe Hepatitis C Virus (HCV) Market Size by Application (2023-2028)
7.3.3 Europe Hepatitis C Virus (HCV) Market Share by Application (2017-2028)
7.4 Europe Hepatitis C Virus (HCV) Market Size by Country
7.4.1 Europe Hepatitis C Virus (HCV) Market Size by Country (2017-2022)
7.4.2 Europe Hepatitis C Virus (HCV) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size (2017-2028)
8.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type
8.2.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hepatitis C Virus (HCV) Market Share by Type (2017-2028)
8.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application
8.3.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hepatitis C Virus (HCV) Market Share by Application (2017-2028)
8.4 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region
8.4.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hepatitis C Virus (HCV) Market Size (2017-2028)
9.2 Latin America Hepatitis C Virus (HCV) Market Size by Type
9.2.1 Latin America Hepatitis C Virus (HCV) Market Size by Type (2017-2022)
9.2.2 Latin America Hepatitis C Virus (HCV) Market Size by Type (2023-2028)
9.2.3 Latin America Hepatitis C Virus (HCV) Market Share by Type (2017-2028)
9.3 Latin America Hepatitis C Virus (HCV) Market Size by Application
9.3.1 Latin America Hepatitis C Virus (HCV) Market Size by Application (2017-2022)
9.3.2 Latin America Hepatitis C Virus (HCV) Market Size by Application (2023-2028)
9.3.3 Latin America Hepatitis C Virus (HCV) Market Share by Application (2017-2028)
9.4 Latin America Hepatitis C Virus (HCV) Market Size by Country
9.4.1 Latin America Hepatitis C Virus (HCV) Market Size by Country (2017-2022)
9.4.2 Latin America Hepatitis C Virus (HCV) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size (2017-2028)
10.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type
10.2.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hepatitis C Virus (HCV) Market Share by Type (2017-2028)
10.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application
10.3.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hepatitis C Virus (HCV) Market Share by Application (2017-2028)
10.4 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country
10.4.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Details
11.1.2 Gilead Business Overview
11.1.3 Gilead Hepatitis C Virus (HCV) Introduction
11.1.4 Gilead Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.1.5 Gilead Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Hepatitis C Virus (HCV) Introduction
11.2.4 Merck Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Hepatitis C Virus (HCV) Introduction
11.3.4 AbbVie Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.3.5 AbbVie Recent Developments
11.4 J&J
11.4.1 J&J Company Details
11.4.2 J&J Business Overview
11.4.3 J&J Hepatitis C Virus (HCV) Introduction
11.4.4 J&J Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.4.5 J&J Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Hepatitis C Virus (HCV) Introduction
11.5.4 Bristol-Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Kawin
11.6.1 Kawin Company Details
11.6.2 Kawin Business Overview
11.6.3 Kawin Hepatitis C Virus (HCV) Introduction
11.6.4 Kawin Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.6.5 Kawin Recent Developments
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Hepatitis C Virus (HCV) Introduction
11.7.4 Abbott Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.7.5 Abbott Recent Developments
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Details
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers Hepatitis C Virus (HCV) Introduction
11.8.4 Siemens Healthineers Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.8.5 Siemens Healthineers Recent Developments
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Details
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics Hepatitis C Virus (HCV) Introduction
11.9.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.9.5 Roche Diagnostics Recent Developments
11.10 altona Diagnostics
11.10.1 altona Diagnostics Company Details
11.10.2 altona Diagnostics Business Overview
11.10.3 altona Diagnostics Hepatitis C Virus (HCV) Introduction
11.10.4 altona Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.10.5 altona Diagnostics Recent Developments
11.11 GeneProof
11.11.1 GeneProof Company Details
11.11.2 GeneProof Business Overview
11.11.3 GeneProof Hepatitis C Virus (HCV) Introduction
11.11.4 GeneProof Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.11.5 GeneProof Recent Developments
11.12 Sansure Biotech
11.12.1 Sansure Biotech Company Details
11.12.2 Sansure Biotech Business Overview
11.12.3 Sansure Biotech Hepatitis C Virus (HCV) Introduction
11.12.4 Sansure Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.12.5 Sansure Biotech Recent Developments
11.13 Daan Gene
11.13.1 Daan Gene Company Details
11.13.2 Daan Gene Business Overview
11.13.3 Daan Gene Hepatitis C Virus (HCV) Introduction
11.13.4 Daan Gene Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.13.5 Daan Gene Recent Developments
11.14 BGI Group
11.14.1 BGI Group Company Details
11.14.2 BGI Group Business Overview
11.14.3 BGI Group Hepatitis C Virus (HCV) Introduction
11.14.4 BGI Group Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.14.5 BGI Group Recent Developments
11.15 Abiores
11.15.1 Abiores Company Details
11.15.2 Abiores Business Overview
11.15.3 Abiores Hepatitis C Virus (HCV) Introduction
11.15.4 Abiores Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.15.5 Abiores Recent Developments
11.16 ACON Biotech
11.16.1 ACON Biotech Company Details
11.16.2 ACON Biotech Business Overview
11.16.3 ACON Biotech Hepatitis C Virus (HCV) Introduction
11.16.4 ACON Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.16.5 ACON Biotech Recent Developments
11.17 Nectar Lifesciences
11.17.1 Nectar Lifesciences Company Details
11.17.2 Nectar Lifesciences Business Overview
11.17.3 Nectar Lifesciences Hepatitis C Virus (HCV) Introduction
11.17.4 Nectar Lifesciences Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.17.5 Nectar Lifesciences Recent Developments
11.18 Everlywell
11.18.1 Everlywell Company Details
11.18.2 Everlywell Business Overview
11.18.3 Everlywell Hepatitis C Virus (HCV) Introduction
11.18.4 Everlywell Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.18.5 Everlywell Recent Developments
11.19 bioLytical
11.19.1 bioLytical Company Details
11.19.2 bioLytical Business Overview
11.19.3 bioLytical Hepatitis C Virus (HCV) Introduction
11.19.4 bioLytical Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.19.5 bioLytical Recent Developments
11.20 Liferiver
11.20.1 Liferiver Company Details
11.20.2 Liferiver Business Overview
11.20.3 Liferiver Hepatitis C Virus (HCV) Introduction
11.20.4 Liferiver Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.20.5 Liferiver Recent Developments
11.21 3B BlackBio Biotech India Limited
11.21.1 3B BlackBio Biotech India Limited Company Details
11.21.2 3B BlackBio Biotech India Limited Business Overview
11.21.3 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Introduction
11.21.4 3B BlackBio Biotech India Limited Revenue in Hepatitis C Virus (HCV) Business (2017-2022)
11.21.5 3B BlackBio Biotech India Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Hepatitis C Drugs
    Table 3. Key Players of Hepatitis C Test Kit
    Table 4. Global Hepatitis C Virus (HCV) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Hepatitis C Virus (HCV) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hepatitis C Virus (HCV) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hepatitis C Virus (HCV) Market Share by Region (2017-2022)
    Table 8. Global Hepatitis C Virus (HCV) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hepatitis C Virus (HCV) Market Share by Region (2023-2028)
    Table 10. Hepatitis C Virus (HCV) Market Trends
    Table 11. Hepatitis C Virus (HCV) Market Drivers
    Table 12. Hepatitis C Virus (HCV) Market Challenges
    Table 13. Hepatitis C Virus (HCV) Market Restraints
    Table 14. Global Hepatitis C Virus (HCV) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hepatitis C Virus (HCV) Revenue Share by Players (2017-2022)
    Table 16. Global Top Hepatitis C Virus (HCV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) as of 2021)
    Table 17. Ranking of Global Top Hepatitis C Virus (HCV) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hepatitis C Virus (HCV) Product Solution and Service
    Table 21. Date of Enter into Hepatitis C Virus (HCV) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2017-2022)
    Table 25. Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2023-2028)
    Table 27. Global Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hepatitis C Virus (HCV) Revenue Share by Application (2017-2022)
    Table 29. Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hepatitis C Virus (HCV) Revenue Share by Application (2023-2028)
    Table 31. North America Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Hepatitis C Virus (HCV) Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Hepatitis C Virus (HCV) Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Gilead Company Details
    Table 62. Gilead Business Overview
    Table 63. Gilead Hepatitis C Virus (HCV) Product
    Table 64. Gilead Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 65. Gilead Recent Developments
    Table 66. Merck Company Details
    Table 67. Merck Business Overview
    Table 68. Merck Hepatitis C Virus (HCV) Product
    Table 69. Merck Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 70. Merck Recent Developments
    Table 71. AbbVie Company Details
    Table 72. AbbVie Business Overview
    Table 73. AbbVie Hepatitis C Virus (HCV) Product
    Table 74. AbbVie Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 75. AbbVie Recent Developments
    Table 76. J&J Company Details
    Table 77. J&J Business Overview
    Table 78. J&J Hepatitis C Virus (HCV) Product
    Table 79. J&J Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 80. J&J Recent Developments
    Table 81. Bristol-Myers Squibb Company Details
    Table 82. Bristol-Myers Squibb Business Overview
    Table 83. Bristol-Myers Squibb Hepatitis C Virus (HCV) Product
    Table 84. Bristol-Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 85. Bristol-Myers Squibb Recent Developments
    Table 86. Kawin Company Details
    Table 87. Kawin Business Overview
    Table 88. Kawin Hepatitis C Virus (HCV) Product
    Table 89. Kawin Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 90. Kawin Recent Developments
    Table 91. Abbott Company Details
    Table 92. Abbott Business Overview
    Table 93. Abbott Hepatitis C Virus (HCV) Product
    Table 94. Abbott Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 95. Abbott Recent Developments
    Table 96. Siemens Healthineers Company Details
    Table 97. Siemens Healthineers Business Overview
    Table 98. Siemens Healthineers Hepatitis C Virus (HCV) Product
    Table 99. Siemens Healthineers Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 100. Siemens Healthineers Recent Developments
    Table 101. Roche Diagnostics Company Details
    Table 102. Roche Diagnostics Business Overview
    Table 103. Roche Diagnostics Hepatitis C Virus (HCV) Product
    Table 104. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 105. Roche Diagnostics Recent Developments
    Table 106. altona Diagnostics Company Details
    Table 107. altona Diagnostics Business Overview
    Table 108. altona Diagnostics Hepatitis C Virus (HCV) Product
    Table 109. altona Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 110. altona Diagnostics Recent Developments
    Table 111. GeneProof Company Details
    Table 112. GeneProof Business Overview
    Table 113. GeneProof Hepatitis C Virus (HCV) Product
    Table 114. GeneProof Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 115. GeneProof Recent Developments
    Table 116. Sansure Biotech Company Details
    Table 117. Sansure Biotech Business Overview
    Table 118. Sansure Biotech Hepatitis C Virus (HCV) Product
    Table 119. Sansure Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 120. Sansure Biotech Recent Developments
    Table 121. Daan Gene Company Details
    Table 122. Daan Gene Business Overview
    Table 123. Daan Gene Hepatitis C Virus (HCV) Product
    Table 124. Daan Gene Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 125. Daan Gene Recent Developments
    Table 126. BGI Group Company Details
    Table 127. BGI Group Business Overview
    Table 128. BGI Group Hepatitis C Virus (HCV) Product
    Table 129. BGI Group Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 130. BGI Group Recent Developments
    Table 131. Abiores Company Details
    Table 132. Abiores Business Overview
    Table 133. Abiores Hepatitis C Virus (HCV) Product
    Table 134. Abiores Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 135. Abiores Recent Developments
    Table 136. ACON Biotech Company Details
    Table 137. ACON Biotech Business Overview
    Table 138. ACON Biotech Hepatitis C Virus (HCV) Product
    Table 139. ACON Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 140. ACON Biotech Recent Developments
    Table 141. Nectar Lifesciences Company Details
    Table 142. Nectar Lifesciences Business Overview
    Table 143. Nectar Lifesciences Hepatitis C Virus (HCV) Product
    Table 144. Nectar Lifesciences Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 145. Nectar Lifesciences Recent Developments
    Table 146. Everlywell Company Details
    Table 147. Everlywell Business Overview
    Table 148. Everlywell Hepatitis C Virus (HCV) Product
    Table 149. Everlywell Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 150. Everlywell Recent Developments
    Table 151. bioLytical Company Details
    Table 152. bioLytical Business Overview
    Table 153. bioLytical Hepatitis C Virus (HCV) Product
    Table 154. bioLytical Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 155. bioLytical Recent Developments
    Table 156. Liferiver Company Details
    Table 157. Liferiver Business Overview
    Table 158. Liferiver Hepatitis C Virus (HCV) Product
    Table 159. Liferiver Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 160. Liferiver Recent Developments
    Table 161. 3B BlackBio Biotech India Limited Company Details
    Table 162. 3B BlackBio Biotech India Limited Business Overview
    Table 163. 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Product
    Table 164. 3B BlackBio Biotech India Limited Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)
    Table 165. 3B BlackBio Biotech India Limited Recent Developments
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hepatitis C Virus (HCV) Market Share by Type: 2021 VS 2028
    Figure 2. Hepatitis C Drugs Features
    Figure 3. Hepatitis C Test Kit Features
    Figure 4. Global Hepatitis C Virus (HCV) Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Ambulatory Surgical Centers Case Studies
    Figure 7. Diagnostic Centers Case Studies
    Figure 8. Hepatitis C Virus (HCV) Report Years Considered
    Figure 9. Global Hepatitis C Virus (HCV) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Hepatitis C Virus (HCV) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Hepatitis C Virus (HCV) Market Share by Region: 2021 VS 2028
    Figure 12. Global Hepatitis C Virus (HCV) Market Share by Players in 2021
    Figure 13. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Revenue in 2021
    Figure 15. North America Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)
    Figure 17. North America Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)
    Figure 18. North America Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)
    Figure 19. United States Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)
    Figure 25. Germany Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Hepatitis C Virus (HCV) Market Size Share by Region (2017-2028)
    Figure 35. China Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)
    Figure 45. Mexico Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)
    Figure 51. Turkey Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Gilead Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 55. Merck Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 56. AbbVie Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 57. J&J Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 59. Kawin Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 60. Abbott Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 61. Siemens Healthineers Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 62. Roche Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 63. altona Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 64. GeneProof Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 65. Sansure Biotech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 66. Daan Gene Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 67. BGI Group Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 68. Abiores Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 69. ACON Biotech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 70. Nectar Lifesciences Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 71. Everlywell Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 72. bioLytical Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 73. Liferiver Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 74. 3B BlackBio Biotech India Limited Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Bacterial Vaginosis Drug Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-17B2476
Thu Jan 26 00:00:00 UTC 2023

Add to Cart

Global Children Influenza Vaccine Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-19X13292
Mon Jan 23 00:00:00 UTC 2023

Add to Cart

Global Thimerosal Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-38G12938
Mon Jan 23 00:00:00 UTC 2023

Add to Cart

Global Quinolone Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-18S13175
Mon Jan 23 00:00:00 UTC 2023

Add to Cart